[AI-based QSAR Modeling for Prediction of Active Compounds in MIE/AOP]

Yakugaku Zasshi. 2020;140(4):499-505. doi: 10.1248/yakushi.19-00190-4.
[Article in Japanese]

Abstract

Toxicity testing is critical for new drug and chemical development process. A clinical study, experimental animal models, and in vitro study are performed to evaluate the safety of a new drug. The limitations of these methods include extensive time for toxicity testing, an ethical problem, and high costs of experimentation. Therefore computational methods are considered useful for estimating chemical toxicity. In silico toxicity prediction is one of the toxicity assessments that uses computational methods to predict and stimulate the toxicity of chemicals. In silico study aims to contribute to effective development of new drug and chemical design. In this study, quantitative structure-activity relationship (QSAR) models will be used to predict toxicities based on chemical structural parameters. Because toxicities are complicated physiological phenomena, a similar toxicity expression might cause a different pathway. Also, since many drugs with unknown mechanisms of actions are available, the application of artificial intelligence (AI)-which uses sophisticated algorithms- is increasingly used to predict toxicities. Recently, the QSAR model was applied to determine complex relations between chemical structures and toxicities. However, accuracy of QSAR for toxicity prediction remains an important issue. International competitions funded by public institutions can address this issue. Two important toxicity challenges were organized in the past decade; this article presents issues of toxicity based on these challenges.

Keywords: adverse effect database; adverse outcome pathway; artificial intelligence; chemical structure; machine learning; quantitative structure-activity relationship.

Publication types

  • Review

MeSH terms

  • Adverse Outcome Pathways*
  • Animal Testing Alternatives
  • Animals
  • Artificial Intelligence*
  • Computer Simulation
  • Drug-Related Side Effects and Adverse Reactions*
  • Models, Animal
  • Quantitative Structure-Activity Relationship*
  • Toxicity Tests / methods